1. Technology overview
Medipixel, Inc. is a medical AI company headquartered in Seoul, South Korea, with a second office in Cambridge, Massachusetts. It develops AI software for cardiovascular and cerebrovascular interventions, aiming to give physicians quantitative information during angiography-guided procedures.
MPXA analyzes coronary X-ray angiography with vessel segmentation and lesion quantification, and MPFFR derives fractional flow reserve (FFR) from angiography for functional assessment. The line also includes MPNeuro cerebrovascular digital twin software and MPXA CoreLab, a research-use tool for retrospective quantification.
2. Highlighted features & specifications
- Vessel segmentation: MPXA segments coronary vessels on X-ray angiography.
- Lesion quantification: MPXA quantifies lesions on angiograms.
- Angiography-derived FFR: MPFFR provides AI-based functional assessment from angiography.
- Cerebrovascular digital twin: MPNeuro is SaMD software certified by MFDS.
- Core lab quantification: MPXA CoreLab offers retrospective cardiovascular quantification for research use only.
- Reporting modules: MPXA Hub, MPXA Report and MPIV are listed in the product line.
3. Potential application
Cath labs can use automated lesion quantification to support stent sizing decisions during PCI. Hospitals without pressure-wire capacity can assess lesion significance with angiography-derived FFR.
4. Benefits
MPXA is listed with MFDS certification and U.S. FDA certification, and MPFFR with MFDS certification. MPFFR derives physiological assessment from angiography images. MPXA CoreLab supports retrospective quantification for research. The vendor offers a demo and brochures for evaluation.
5. Market trends & opportunities
Interventional cardiology is moving toward physiology-guided PCI and pressure-wire-free FFR, which reduces procedure time and cost. Vietnamese cath labs are expanding PCI volumes and could evaluate angiography-based analysis, though the site shows no Vietnamese presence.
6. Other information
Headquartered in Seoul with an office in Cambridge, USA. Named to TIME's World's Top HealthTech Companies 2025 and received NET certification in July 2025. MDSAP certification in December 2024 and ISO 13485 certification in December 2023.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































